EGFR and lung adenocarcinoma: The EGFR gene, which encodes a transmembrane tyrosine kinase, is a commonly mutated gene in lung adenocarcinoma and is more frequently observed in elderly patients (≥60 years old), with a mutation rate of approximately 15%–50% [16].